Celcuity Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
155
IPO date
Sep 20, 2017

Celcuity Inc. is a clinical-stage biotechnology company that develops cancer drugs aimed at specific tumor signaling pathways. Its main work is to identify which patients are most likely to respond to a treatment and then advance drugs that block the biological signals helping cancer cells grow. The company’s lead programs are built around targeted therapies rather than broad chemotherapy, so its business depends on matching the right drug to the right cancer biology.

Celcuity does not sell a wide range of commercial medicines. It makes money mainly through drug development activities, which can include licensing, collaboration payments, and future product sales if its candidates win approval. Its research platform is used to study patient tumor samples and help guide clinical trial design, which gives the company a role both as a drug developer and as a precision-medicine toolmaker.

For investors, the key point is that Celcuity sits in the high-risk, high-reward part of biotech. It is trying to turn lab and clinical data into approved cancer treatments that address patients with specific molecular markers. That makes its business model different from a traditional drugmaker: most of its value depends on successful clinical testing, regulatory approval, and eventual adoption by oncologists and hospitals.

Celcuity Inc Investor Relations

Address
16305 36th Ave N Ste 100
Minneapolis, Minnesota
United States of America

Business Segments

Drug development

Celcuity develops cancer drugs, with most of its work centered on advancing gedatolisib through clinical trials and regulatory steps.

Customers and revenue model

Management

Mr. Brian F. Sullivan

Co-Founder, Chairman & CEO

Biography unavailable

Dr. Lance G. Laing Ph.D.

Co-Founder, Chief Science Officer, VP, Secretary & Director

Biography unavailable

Mr. Brent Eilefson

General Counsel

Biography unavailable

Dr. John R. MacDonald Dabt, Ph., Ph.D.

Senior Vice President of R&D

Biography unavailable

Ms. Sheri Smith

Acting Head of Clinical Operations

Biography unavailable

Mr. Igor Gorbatchevsky M.D.

Chief Medical Officer

Biography unavailable

Mr. Eldon C. Mayer III, M.B.A.

Chief Commercial Officer

Biography unavailable

Dr. Charlotte Moser M.B.A., M.D., M.Sc., Ph.D.

Senior Vice President of Clinical Development

Biography unavailable

1 / 8